Cairo – Mubasher: DBK Pharmaceutical seeks to achieve EGP 227 million in revenues in 2016, in addition to raising its exports especially to the GCC, said Chairman and Managing Director, Hamdy Al Debeiky.
Meanwhile, the company targets net profits of 90 million in 2016, added Al Debeiky in Exclusive statement to Mubasher.
The drug firm plans to launch a private placement for 37.29 million shares, or 25% of capital at a price of EGP 3.25 per share.
DBK Pharmaceutical owns a factory in Obour City spreads over 3000 square meters and plans to establish two other new schemes through 2017 and 2018 at total estimated investments of EGP 60 million, noted Al Debeiky.
The firm exports its products to around 18 countries all over Aisa and Africa.